Product
PD-1 inhibitors
1 clinical trial
2 indications
Indication
Hepatocellular CarcinomaIndication
Portal Vein ThrombosisClinical trial
Hepatic Arterial Infusion Chemotherapy Combine With Lenvatinib and PD-1 Inhibitors for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.Status: Recruiting, Estimated PCD: 2023-12-29